A National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma.
Clinical trial NCT02068196 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02068196
- Sponsor
- Oslo University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2025-12-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.